DCN Diagnostics (@DCNDiagnostics) header
DCN Diagnostics (@DCNDiagnostics) profile picture

DCN Dx specializes in contract development of rapid point of care tests. We also offer education, cassette design, gap manufacturing, & lateral flow kits.

Carlsbad, CA
Joined July 2015
Photo by DCN Diagnostics (@DCNDiagnostics)Photo by DCN Diagnostics (@DCNDiagnostics)Photo by DCN Diagnostics (@DCNDiagnostics)Photo by DCN Diagnostics (@DCNDiagnostics)Photo by DCN Diagnostics (@DCNDiagnostics)Photo by DCN Diagnostics (@DCNDiagnostics)Photo by DCN Diagnostics (@DCNDiagnostics)Photo by DCN Diagnostics (@DCNDiagnostics)Photo by DCN Diagnostics (@DCNDiagnostics)Photo by DCN Diagnostics (@DCNDiagnostics)
Some assays cannot remain frozen in time when the target they detect is changing. Using hantavirus as an example, Jesse Young, Ph.D., asks how oversight should account for tests that must evolve to keep serving a regional population. #LDT #IVD #Diagnostics
1
107
In this Expert Insights article, DCN Dx COO Dr. Pat Vaughan breaks down the semi-quantitative #LFA format: cut-off engineering, reader selection, and the design decisions that determine whether semi-quantitative is the right call for your program. Link in comments. #LateralFlow
1
10
Who counts as a "naive operator" in a #CLIA waiver study is more specific than teams assume. Emily Friedland (VP, #ClinicalResearch) and Dan Simpson (Director, #RegulatoryAffairs) explain how to design the comparison study for a molecular diagnostic. Link in comments. #IVD
1
16
Developing or validating a molecular diagnostic assay? Meet DCN Dx at #AMP2026 in Seattle, Nov. 12–14. Find us at booth 1031 to discuss clinical research, regulatory affairs, and #biospecimens. #MolecularDiagnostics #IVD #CRO
2
1
73
Patient volume doesn’t guarantee IVD study enrollment. On Expert Insights, Emily Friedland, Lara Poznak, and Missy Farrell discuss respiratory and STI enrollment barriers. Heading to AMP 2026? Listen before you go. Link in the first reply. #AMP2026 #IVD
1
33
Listen on Spotify or your favorite podcast platform: open.spotify.com/episode/3cL…
8
Developing or validating a molecular diagnostic assay? Meet DCN Dx at #AMP2026 in Seattle, Nov. 12–14. Find us at booth 1031 to discuss clinical research, regulatory affairs, and #biospecimens. #MolecularDiagnostics
1
2
1
93
The #miniDxR is a customizable #lateralflow reader designed for point-of-care settings, combining quantitative readout accuracy with a form factor practical for both development environments and clinical deployment. Learn more: hubs.ly/Q04DMmgT0 #PointOfCare #IVD
17
Patient volume doesn’t guarantee IVD study enrollment. On Expert Insights, Emily Friedland, Lara Poznak, and Missy Farrell discuss respiratory and STI enrollment barriers. Heading to AMP 2026 this week? Listen before you go. Link in the first reply. #AMP2026 #IVD
1
18
Listen on Spotify or your favorite podcast platform: open.spotify.com/episode/3cL…
4
Developing or validating a molecular diagnostic assay? Meet DCN Dx at #AMP2026 in Seattle, Nov. 12–14. Find us at booth 1031 to discuss clinical research, regulatory affairs, and #biospecimens. #MolecularDiagnostics
1
2
2
110
The next respiratory wave will not wait for your study team to finish planning. Listen to Expert Insights this weekend. Next week, ask: Is our CRO selected, are the right sites engaged, and are we ready to enroll? Link 👇 #IVD #ClinicalTrials #RespiratoryDiagnostics #CRO
1
19
Developing or validating a molecular diagnostic assay? Meet DCN Dx at #AMP2026 in Seattle, Nov. 12–14. Find us at booth 1031 to discuss clinical research, regulatory affairs, and #biospecimens. #MolecularDiagnostics
1
2
1
95